TY  - JOUR
AU  - Burgaz, Sonia
AU  - García, Concepción
AU  - Gonzalo-Consuegra, Claudia
AU  - Gómez-Almería, Marta
AU  - Ruiz-Pino, Francisco
AU  - Unciti, Juan Diego
AU  - Gómez-Cañas, María
AU  - Alcalde, Juan
AU  - Morales, Paula
AU  - Jagerovic, Nadine
AU  - Rodríguez-Cueto, Carmen
AU  - de Lago, Eva
AU  - Muñoz, Eduardo
AU  - Fernández-Ruiz, Javier
PY  - 2021
DO  - 10.3390/molecules26247643
UR  - https://hdl.handle.net/10668/25633
T2  - Molecules (Basel, Switzerland)
AB  - Cannabinoids act as pleiotropic compounds exerting, among others, a broad-spectrum of neuroprotective effects. These effects have been investigated in the last years in different preclinical models of neurodegeneration, with the cannabinoid type-1...
LA  - en
KW  - 6-hydroxydopamine
KW  - GPR55 receptors
KW  - Parkinson’s disease
KW  - TDP-43 transgenic mice
KW  - VCE-006.1
KW  - amyotrophic lateral sclerosis
KW  - cannabinoids
KW  - chromenopyrazole
KW  - lipopolysaccharide
KW  - mSOD1 mice
KW  - Amyotrophic Lateral Sclerosis
KW  - Animals
KW  - Disease Models, Animal
KW  - Humans
KW  - Ligands
KW  - Male
KW  - Mice
KW  - Mice, Transgenic
KW  - Neuroglia
KW  - Neuroprotective Agents
KW  - Parkinson Disease
KW  - Receptors, Cannabinoid
KW  - Substantia Nigra
KW  - U937 Cells
TI  - Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson's Disease and Amyotrophic Lateral Sclerosis.
TY  - research article
VL  - 26
ER  -